Inrig Jula
SEC insider (Form 3/4/5 filer). CIK 0001902368. EVP, Head of R&D & CMO at Travere Therapeutics, Inc. (TVTX). 34 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in SAN DIEGO, CA.
Companies Inrig Jula has filed insider reports for
- Travere Therapeutics, Inc. (TVTX): Officer, EVP, Head of R&D & CMO
Inrig Jula
CIK: 0001902368
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Travere Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (34 total)
- Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect25.4K shares at avg. $62.02$1.6M - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect1.6K shares at avg. $63.69$102K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect400 shares at avg. $65.31$26K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect32.4K shares at avg. $8.93$289K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect17.3K shares at avg. $62.62$1.1M - Jun 22, 2026TVTX
Travere Therapeutics, Inc.
GiftDirect468 shares- - May 6, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect311 shares at avg. $43.95$14K - May 5, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect2.2K shares at avg. $46.65$101K - May 4, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect4.3K shares- - May 4, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect20K shares at avg. $45.00$900K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 25,390 | $62.02 | $1,574,604 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 1,600 | $63.69 | $101,896 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 400 | $65.31 | $26,124 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 32,395 | $8.93 | $289,287 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 17,284 | $62.62 | $1,082,397 | Direct |
| Jun 22, 2026 | TVTX Travere Therapeutics, Inc. | Gift | 468 | - | $0 | Direct |
| May 6, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 311 | $43.95 | $13,668 | Direct |
| May 5, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 2,174 | $46.65 | $101,417 | Direct |
| May 4, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 4,250 | - | $0 | Direct |
| May 4, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 20,000 | $45.00 | $900,000 | Direct |
1-10 of 34 transactions